One day, each one of us—or our loved ones—will be a patient in need. When that day comes, the cost and quality of the treatments available to us will hinge on the decisions Congress and the White House make today to embrace innovation or to undermine it.
Paul Howard and Peter W. Huber
ABOUT THE BOOK
New medicines in the pipeline can extend lives, save money, and even help stop disease before symptoms appear—if we don’t discourage their innovators and investors by trying to lower drug prices artificially. Unlocking Precision Medicine explores the environment necessary for creation of these health care game changers, and explains how the marketplace can effectively make them more affordable to all without killing the golden goose.
______________________
Paul Howard is a senior fellow and director of health policy at the Manhattan Institute. Follow him on Twitter here.
Peter W. Huber is a senior fellow at the Manhattan Institute.